Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Friday, April 19, 2024.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Crossroads (-60) - NBIX is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid NBIX?
MarketClub looks at technical strength and momentum to determine if the timing is right for NBIX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for NBIX
The long-term trend has been UP since Aug 21st, 2023 at 107.980
The intermediate-term trend has been DOWN since Apr 15th, 2024 at 133.425
The short-term trend has been DOWN since Apr 11th, 2024 at 137.090
Smart Scan Analysis for NBIX
Based on our trend formula, NBIX is rated as a -60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 132.650 | 133.650 | 130.130 | 132.055 | -0.485 |
| Prev. Close | Volume | Bid | Ask | Time |
| 132.540 | 399895 | 2024-04-19 15:59:25 |
| Year High | 126.98 | Year High Date | 2018-09-13 |
| Year Low | 74.12 | Year Low Date | 2018-01-17 |
| 52wk High | 148.3699 | 52wk High Date | 2024-03-21 |
| 52wk Low | 89.04 | 52wk Low Date | 2023-05-30 |
| Year End Close | 7.48 | Average Volume | 874,964 |
| Shares Outstanding | 99,507 | Short Interest | 2,757,358 |
| % Institutional | 82.1 | Market Cap | 8,737M |
| Assets | 325,140,000M | Liabilities | 101,940,000M |
| P/E Ratio | 53.6599 | Beta | 0.3 |
| Volatility | 65.12 |